Once-Daily Rheumatoid Arthritis Treatment Submitted for Review

Once-Daily Rheumatoid Arthritis Treatment Submitted for Review

"Lilly's collaboration with Incyte has produced a rigorous phase 3 program and, if approved, the potential of a promising new treatment option for people with RA [rheumatoid arthritis]," said David Ricks, president of Lilly Bio-Medicines, in a press

(Visited 1 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.